Atlas FDA

Aptima CMV Quant Assay

FDA premarket approval P210029 · decided 2022-05-09

Approval details

PMA number
P210029
Trade name
Aptima CMV Quant Assay
Generic name
Cytomegalovirus (cmv) dna quantitative assay
Applicant
Hologic, Inc.
Date received
2021-07-26
Decision date
2022-05-09
Days to decision
287 days
Decision code
APRL
Product code
PAB
Advisory committee
Microbiology
Expedited review
No
Location
San Diego, CA
Statement
Approval of The Aptima CMV Quant Assay - This device is approved for:The Aptima CMV Quant Assay is an in vitro nucleic acid amplification test for the quantitation of human cytomegalovirus (CMV) DNA in human EDTA plasma on the fully automated Panther system. The Aptima CMV Quant Assay is intended for use to aid in the management of solid-organ transplant patients and hematopoietic stem cell transplant patients. In patients receiving anti-CMV therapy, serial DNA measurements can be used to assess

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CoolSeal Generator® (CSL-200-90) (K253634)Hologic, Inc.2026-06-17
Panther Fusion GI Expanded Bacterial Assay (K251993)Hologic, Inc.2025-09-25
Genius AI Detection 2.0 (K243341)Hologic, Inc.2025-07-31
Aptima SARS-CoV-2 Assay (K243396)Hologic, Inc.2025-02-13
Aptima CMV Quant Assay (K243935)Hologic, Inc.2025-01-17
Aptima BV Assay; Aptima CV/TV Assay (K243345)Hologic, Inc.2024-11-25
Panther Fusion SARS-CoV-2/Flu A/B/RSV assay (K242465)Hologic, Inc.2024-11-15
Fluent Pro Fluid Management System (FLT-200); Fluent Pro Fluid Management System Disposable Procedure Kit (6-pack) (FLT-212); Fluent Pro Fluid Management System Disposable Procedure Kit (1-pack) (FLT-212S); Fluent Pro Fluid Management System Tissue Trap Multipack (10-pack) (FLT-210); Fluent Pro Fluid Management System Waste Bag Multipack (5-pack) (FLT-205) (K240886)Hologic, Inc.2024-07-25